Transcriptomic profiles of neoantigen-reactive T cells in human gastrointestinal cancers

Cancer Cell. 2022 Apr 11;40(4):410-423.e7. doi: 10.1016/j.ccell.2022.03.005.

Abstract

Tumor-infiltrating neoantigen-reactive T cells can mediate regression of metastatic gastrointestinal cancers yet remain poorly characterized. We performed immunological screening against personalized neoantigens in combination with single-cell RNA sequencing on tumor-infiltrating lymphocytes from bile duct and pancreatic cancer patients to characterize the transcriptomic landscape of neoantigen-reactive T cells. We found that most neoantigen-reactive CD8+ T cells displayed an exhausted state with significant CXCL13 and GZMA co-expression compared with non-neoantigen-reactive bystander cells. Most neoantigen-reactive CD4+ T cells from a patient with bile duct cancer also exhibited an exhausted phenotype but with overexpression of HOPX or ADGRG1 while lacking IL7R expression. Thus, neoantigen-reactive T cells infiltrating gastrointestinal cancers harbor distinct transcriptomic signatures, which may provide new opportunities for harnessing these cells for therapy.

Keywords: adoptive cell therapy; bile duct cancer; cancer immunotherapy; gastrointestinal cancers; neoantigen; pancreatic cancer; single-cell RNA-seq; tumor-infiltrating lymphocytes.

MeSH terms

  • Antigens, Neoplasm
  • CD8-Positive T-Lymphocytes*
  • Gastrointestinal Neoplasms* / genetics
  • Humans
  • Lymphocytes, Tumor-Infiltrating
  • Transcriptome

Substances

  • Antigens, Neoplasm